Items where authors include "Duce, JA"

Article

Lewis, FW, Bird, K, Navarro, J-P et al. (9 more authors) (2022) Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1H)-one iron chelators in an in vitro cell model of Parkinson's disease. Dalton Transactions, 51 (9). pp. 3590-3603. ISSN 1477-9226

Tsatsanis, A, McCorkindale, AN, Wong, BX et al. (8 more authors) (2021) The acute phase protein lactoferrin is a key feature of Alzheimer's disease and predictor of A beta burden through induction of APP amyloidogenic processing. Molecular Psychiatry, 26. pp. 5516-5531. ISSN 1359-4184

Gunn, AP, Wong, BX, McLean, C et al. (4 more authors) (2021) Increased glutaminyl cyclase activity in brains of Alzheimer’s disease individuals. Journal of Neurochemistry, 156 (6). pp. 979-987. ISSN 0022-3042

Devos, D, Moreau, C, Kyheng, M et al. (17 more authors) (2020) Author Correction: A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports, 10. 3312. ISSN 2045-2322

Devos, D, Moreau, C, Kyheng, M et al. (17 more authors) (2019) A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports, 9. 2918. ISSN 2045-2322

Tsatsanis, A, Dickens, S, Kwok, JCF orcid.org/0000-0002-9798-9083 et al. (2 more authors) (2019) Post Translational Modulation of β-Amyloid Precursor Protein Trafficking to the Cell Surface Alters Neuronal Iron Homeostasis. Neurochemical Research, 44 (6). pp. 1367-1374. ISSN 0364-3190

Taylor-Whiteley, TR, Le Maitre, CL, Duce, JA orcid.org/0000-0002-8762-2245 et al. (2 more authors) (2019) Recapitulating Parkinson's disease pathology in a three-dimensional human neural cell culture model. Disease Models & Mechanisms, 12 (4). dmm038042. ISSN 1754-8403

Lopez Sanchez, MIG, Waugh, HS, Tsatsanis, A et al. (4 more authors) (2017) Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta. Scientific Reports, 7 (1). 9835. ISSN 2045-2322

Duce, JA orcid.org/0000-0002-8762-2245, Wong, BX, Durham, H et al. (3 more authors) (2017) Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson’s disease. Molecular Neurodegeneration, 12. 45. ISSN 1750-1326

Arber, C, Angelova, PR, Wiethoff, S et al. (11 more authors) (2017) iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease. PLOS ONE, 12 (9). ARTN e0184104. ISSN 1932-6203

Laloux, C, Gouel, F, Lachaud, C et al. (11 more authors) (2017) Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson’s disease? Neurobiology of Disease, 103. pp. 24-31. ISSN 0969-9961

Lei, P, Ayton, S, Appukuttan, AT et al. (12 more authors) (2017) Lithium suppression of tau induces brain iron accumulation and neurodegeneration. Molecular Psychiatry, 22 (3). pp. 396-406. ISSN 1359-4184

Lam, LQ, Wong, BX, Frugier, T et al. (5 more authors) (2017) Oxidation of Iron under Physiologically Relevant Conditions in Biological Fluids from Healthy and Alzheimer's Disease Subjects. ACS Chemical Neuroscience, 8 (4). pp. 731-736. ISSN 1948-7193

Poujois, A, Devedjian, JC, Moreau, C et al. (4 more authors) (2016) Bioavailable Trace Metals in Neurological Diseases. Current Treatment Options in Neurology, 18 (10). 46. ISSN 1092-8480

Workman, DG, Tsatsanis, A, Lewis, FW et al. (7 more authors) (2015) Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators. Metallomics, 7 (5). 867 - 876. ISSN 1756-5901